Portland Investment Counsel’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.34M Buy
1,458
+291
+25% +$295K 0.43% 29
2025
Q4
$1.26M Buy
1,167
+302
+35% +$289K 0.38% 27
2025
Q3
$660K Hold
865
0.18% 38
2025
Q2
$674K Hold
865
0.2% 36
2025
Q1
$714K Hold
865
0.22% 30
2024
Q4
$668K Buy
+865
New +$716K 0.17% 37

Other funds holding LLY

Portland Investment Counsel's LLY Position: Q1 2026 in Review

Portland Investment Counsel increased its Eli Lilly (LLY) stake by 25% in Q1 2026, buying an estimated $295K and bringing the position to 1,458 shares worth $1.34M. The position accounts for 0.43% of the portfolio, ranked #29.

Portland Investment Counsel first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. 4,356 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Portland Investment Counsel held 1,458 shares of Eli Lilly worth $1.34M as of Q1 2026.
  • Portland Investment Counsel bought 291 Eli Lilly shares in Q1 2026, an estimated $295K.
  • Eli Lilly made up 0.43% of Portland Investment Counsel's portfolio in Q1 2026, its #29 holding.
  • Portland Investment Counsel first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 4,356 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Portland Investment Counsel's 13F filing for Q1 2026, filed 14 May 2026.